Epidemiology of Human Papillomavirus Infection

REFERENCES

• Dillner J, Kallings I, Brihmer C, Sikström B, Koskela P. Lehtinen M, et al. Seropositivity to human papilloma- virus types 16, 18 or 33 capsids and to Chlamydia trachomatis are markers of sexual behaviour. J Infect Dis 1996; 173: 1394–8.
   Google Scholar
• Andersson-Ellström A, Dillner J, Hagmar B, Schiller J, Forssman L. No serological evidence for non-sexual spread of HET 16. Lancet 1994; 344: 1435.
   Google Scholar
• Andersson-Ellström A, Dillner J, Hagmar B, Schiller J, Sapp M, Forssman L, Milsom I. Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA amongsexually experienced and virginal young girls. A long- itudinal cohort study. Sex Transm Dis 1996; 23: 234–8.
   Google Scholar
• Evander M, Edlund K, Gustafsson A, Jonsson M, Karlsson R, Rylander E, et al. Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis 1995; 171: 1026–30.
   PubMed Web of Science ®Google Scholar
• Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994; 169: 235–40.
   PubMed Web of Science ®Google Scholar
• Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infec-tion in young women. N Engl J Med 1998; 338: 423–8.
   Google Scholar
• Nonnenmacher B, Hubbert NIL, Kimbauer R, Shah KV, Munoz N, Bosch FX, et al. Serologic response to human papillomavirus type 16 virus-like particles in HPV 16 DNA-positive invasive cervical cancer and cervicalintraepithelial neoplasia grade III patients and controls from Colombia and Spain. J Infect Dis 1995; 172: 19–24.
   PubMed Web of Science ®Google Scholar
• Remmink AJ, Walboomers JMM, Helmerhorst ThJM, Voorhorst FJ, Rozendaal L, Risse EKJ, et al. The presence of persistent high risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995; 61: 306–11.
   PubMed Web of Science ®Google Scholar
• Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, et al. Type-specific persistence of human papillomavirus before invasive cervical cancer. N Engl J Med 1999; 341: 1633–8.
   PubMed Web of Science ®Google Scholar
• Grussendorf-Conen El, de Villiers EM, Gissmann L. Human papillomavirus genomes in penile smears of healthy men. Lancet 1986; 2: 1092.
   Google Scholar
• Cupp MR, Malek RS, Goellner JR, Smith TF, Espy MJ. The detection of human papillomavirus deoxyribo-nucleic acid in intrae verrucous and invasive carcinoma of the penis. J Urol 1995; 154: 1024–9.
   Google Scholar
• Wikström A, Popescu C, Forslund O. Asymptomatic penile HPV infection: a prospective study. Int STD AIDS 2000; 11: 80–4.
   PubMed Web of Science ®Google Scholar
• Koutsky L. Epidemiology of genital human papilloma-virus infection. Am J Med 1997; 102: 3–8.
   PubMedGoogle Scholar
• van den Eeden SK, Habel L, Sherman KJ, McKnight B, Stergachis A, Haling JR. Risk factors for incident and recurrent condylomata acuminata among men. Sex Transm Dis 1998; 25: 278–84.
   PubMed Web of Science ®Google Scholar
• Hippeldinen M, Syrjänen S, Koskela H, Pulkkinen J, Saarikoski S, Syrjänen K. Prevalence and risk factors of genital human papillomavirus (I-UT) infections in healthy males: a study on Finnish conscripts. Sex Transm Dis 1993; 20: 321–8.
   PubMed Web of Science ®Google Scholar
• Castellsague X, Ghaffari A, Daniel RW, Bosch FX, Munoz N, Shah Ky. Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis 1997; 176: 353–61.
   PubMed Web of Science ®Google Scholar
• Bosch FX, Castellsague X, Munoz N, de Sanjose S, Ghaffari AM, Gonzalez LC, et al. Male sexual behaviour and human papillomavirus DNA: key risk factors in Spain. J Nati Cancer Inst 1996; 88: 1060–7.
   Google Scholar
• Griffiths TR, Mellon JK. Human papillomavirus and urological tumours: I. Basic science and role. Br J Urol Int 1999; 84: 579–86.
   Google Scholar
• Munoz N, Castellsague X, Bosch FX, Tafur L, de Sanjose S, Aristizabal N, et al. Difficulty in elucidating the male role in cervical cancer in Colombia, a high risk area for the disease. J Nati Cancer Inst 1996; 88: 1068–75.
   PubMedGoogle Scholar
• Barasso R, de Brux J, Croissant O, Orth G. High prevalence of papillomavirus associated penile intraepi-thelial neoplasia of the sexual partners of women with cervical intraepithelial neoplasia. N Engl J Med 1987; 317: 916–23.
   PubMed Web of Science ®Google Scholar
• Bleeker M, Hogewoning C, Voorhorst FJ, van den Brule AJC, Meijer CJLM. Prevalence of HPV and penile lesions in male partners of women with CIN. 2000: in preparation..
   Google Scholar
• Malek RS, Goellner JR, Smith TF, Espy MJ, Cupp MR. Human papillomavirus infection and intraepithelial in situ and invasive carcinoma of the penis. Urology 1993; 42: 159–70.
   Google Scholar
• Aynaud O, Ionesco M, Barasso R. Penile intraepithelial neoplasia. Specific clinical features correlate with histo-logic and virologic findings. Cancer 1994; 74: 1762–7.
   Google Scholar
• Rubin MA, Kleter B, Zhou M, Ayala G, Cubilla A, Quint WGV, et al. Detection of human papillomaviruses in penile condyloma, dysplasia and invasive carcinomas using a novel line probe assay for rapid detection and simultaneous identification of 25 different HPV types. J Urol 2000; 163: 4, abstract 639.
   Google Scholar
• Fleisch PM. The detection of human papillomavirus deoxyribonucleic acid in in situ, verrucous and invasive carcinoma of the penis. J Urol 1996; 155: 2035–6.
   PubMed Web of Science ®Google Scholar
• Gregoire L, Cubilla AL, Reuter VE, Haas GP, Lancaster WD. Preferential association of human papillomavirus with high-grade histological penile-invasive squamous cell carcinoma. J Nati Cancer Inst 1995; 87: 1705–9.
   Google Scholar
• IARC monographs on the evaluation of carcinogenic risks of humans. Volume 64: Human papilloma viruses. Lyon, France: IARC, 1995.
   Google Scholar
• Walboomers JMM, de Roda Husman AM, van den Brule AJC, Snijders PJF, Meijer CJLM. Detection of genital human papillomavirus infections: Critical review of methods and prevalence studies in relation to cervical cancer. In: Stem PL, Stanley MA, eds. Human papillo-maviruses and cervical cancer. Oxford: Oxford Uni-versity Press, 1994: 41–71.
   Google Scholar
• Walboomers JMM, Jacobs MV, van Oostveen JVV, van den Brule AJC, Snijders PJF, Meijer CJLM. Detection of genital human papillomavirus infections and possible clinical implications. In: Gross G, von Krogh G, eds. Human papillomavirus infections in dermatovenereol-ogy. 1997: 341–64.
   Google Scholar
• Melchers WJ, Bakker JM, Waag J, de Wilde PC, Boonstra H, Quint WG, et al. Short fragment polymer chain reaction reverse hybridisation line probe assay to detect and genotype a broad spectrum of human papillomavirus types: clinical evaluation and follow up. Am J Pathol 1999; 155: 1473–78.
   Google Scholar
• Cubilla AL, Velazquez EF, Reuter VE, Oliva E, Mihm Jr MC, Young RH. Warty (condylomatous) squamous cell carcinoma of the penis: a report proposing classification of `verruciform' penile tumors. Am J Surg Pathol 2000; 24: 505–12.
   PubMed Web of Science ®Google Scholar
• Cubilla AL, Reuter VE, Grogoire L, Ayala G, Ocampos S, Lancaster WD, et al. Basaloid squamous cell carci-noma: a distinctive human papillomavirus neoplasm: a report of 20 cases. Am J Surg Pathol 1998; 22: 755–61.
   PubMed Web of Science ®Google Scholar
• Ranki A, Lassus J, Niemi KM. Relation of p53 tumor suppressor protein expression to human papillomavirus (HIT) DNA and to cellular atypia in male genital warts and in premalignant lesions. Acta Derm Venereol 1995; 75: 180–6.
   Google Scholar
• Levi JE, Rahal P. Sarkis AS, Villa L. Human papillomavirus DNA and p53 status in penile carcinoma. Int J Cancer 1998; 76: 779–83.
   PubMed Web of Science ®Google Scholar
• Leis PF, Stevens KR, Baer SC, Kadmon D, Goldberg LH, Wang XJ. A c-rasHa mutation in the metastasis of a human papilloma (HPV)-18 positive penile squamous cell carcinoma suggests cooperative effect between HPV-18 and c-rasHa activation in malignant progres-sion. Cancer 1998; 83: 122–9.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Sato N, Kodama T, Okano T, Isaka S, Shirarawa H, et al. Detection of human papillomavirus DNA and state of p53 gene mutations in Japanese penile cancer. Jpn J Clin Oncol 1994; 24: 1–6.
   PubMed Web of Science ®Google Scholar
• Kjaer SK, de Villiers EM, Caglayan H, Svare E, Haugaard BJ, Engholm G, et al. Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark)-A second look. Br J Cancer 1993; 67: 830–7.
   PubMed Web of Science ®Google Scholar
• Reeves WC, Gary HE, Johnson PR, Icenogle JP, Brenes MM, deBritton RM, et al. Risk factors for genital papillomavirus infection in populations at high and low risk for cervical cancer. J Infect Dis 1994; 170: 753–8.
   PubMed Web of Science ®Google Scholar
• Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12–9.
   PubMed Web of Science ®Google Scholar
• Jacobs MV, Snijders PJF, Vorhorst FJ, Dillner J, Forslund O, Johansson B, et al. Reliable high risk HPV DNA testing by polymerase chain reaction: An inter-method and intramethod comparison. J Clin Pathol 1999; 52: 498–503.
   PubMed Web of Science ®Google Scholar
• Carter JJ, Koutsky LA, Wipf GC, Christensen ND, Lee SK, Kuypers J, et al. The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis 1996; 174: 927–36.
   PubMed Web of Science ®Google Scholar
• Kimbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT. A virus-like particle ELISA detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Nati Cancer Inst 1994; 86: 494–9.
   PubMedGoogle Scholar
• Kjellberg L, Wang Z, Wildund F, Edlund K, Angstrom T, Lenner P. et al. Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a popula-tion-based case-control study. J Gen Virol 1999; 80: 391–8.
   PubMed Web of Science ®Google Scholar
• Wideroff L, Schiffman MH, Nonnenmacher B, Hubbert NL, Kirnbauer R, Greer CE, et al. Evaluation of sero-reactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J Infect Dis 1995; 172: 1425–30.
   PubMed Web of Science ®Google Scholar
• Wideroff L, Schiffman MH, Hoover R, Tarone RE, Nonnenmacher B, Hubbert N, et al. Epidemiologic determinants of seroreactivity to human papillomavirus (HM) type 16 virus-like particles in cervical HPV16 DNA-positive and negative women. J Infect Dis 1996; 174: 937–94.
   PubMed Web of Science ®Google Scholar
• Viscidi RP, Kotloff KL, Clayman B, Russ K, Shapiro S, Shah KV. Prevalence of antibodies to human papilloma-virus (HM) type 16 virus-like particles in relation to cervical HPV infection among college women. Clin Diagn Lab Immunol 1997; 4: 122–6.
   PubMedGoogle Scholar
• Gruijl TD, Bontkes HJ, Walboomers JMM. Immunoglo-bulin G responses against human papillomavirus type 16 virus-like particles in a prospective non intervention cohort study of women with cervical intraepethelial neoplasia. J Natl Cancer Inst 1997; 89: 630–8.
   Google Scholar
• Roden RBS, Lowy DR, Schiller JT. Papillomavirus is resistant to desiccation. J Infect Dis 1997; 176: 1076–9.
   Google Scholar
• Dillner J. The serological response to papillomaviruses. Semin Cancer Biol 1999; 9: 423–30.
   PubMed Web of Science ®Google Scholar
• af Geijersstam V, Eklund C, Wang Z, Sapp M, Schiller JT, Dillner J, et al. A survey of seroprevalences of human papillomavirus types 16,18 and 33 among children. Int J Cancer 1999; 80: 489–93.
   PubMed Web of Science ®Google Scholar
• Mund K, Han C, Daum R, Helfrich S, Mueller M, Fisher SG, et al. Detection of human papillomavirus type 16 DNA and of antibodies to human papillomavirus type 16 proteins in children. Intervirology 1997; 40: 232–7.
   PubMed Web of Science ®Google Scholar
• Dillner J, Andersson-Ellström A, Hagmar B, Schiller JT. High risk genital papillomavirus infections are not spread vertically. Rev Med Virol 1999; 9: 23–9.
   PubMed Web of Science ®Google Scholar
• Wikström A, Van Doomum GJJ, Quint WGV, Schiller JT, Dillner J. Identification of human papillomavirus seroconversions. J Gen Virol 1995; 76: 529–39.
   Google Scholar
• Wikström A, van Doomum GJJ, Kimbauer R, Quint WGV, Dillner J. A prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infection. J Med Virol 1995; 46: 368–74.
   Google Scholar
• af Geijersstam V, Kibur M, Wang Z, Koskela P. Pukkala E, Schiller JT, et al. Stablity over time of Human Papillomavirus type 16 antibody levels. J Infect Dis 1998; 177: 1710–4.
   PubMed Web of Science ®Google Scholar
• Shah KV, Viscidi RP, Alberg AJ, Helzlsouer KJ, Comstock GW. Antibodies to human papillomavirus 16 and subsequent in situ or invasive cancer of the cervix. Cancer Epidemiol Biomarkers Prevention 1997; 6: 233–7.
   Google Scholar
• Olsen AOO, Dillner J, Gjöen K, Magnus P. Seropositiv-ity against HPV16 capsids: A better marker of past sexual behaviour than presence of HET DNA. Genitour-in Med 1997; 73: 131–5.
   Google Scholar
• Wang Z, Kjellberg L, Abdalla H, Wiklund F, Eklund C, Knekt P. et al. Type specificity and significance of different isotypes of serum antibodies to human papillomavirus capsids. J Infect Dis 2000; 181: 456–62.
   PubMed Web of Science ®Google Scholar
• Hildesheim A, Gravitt P. Schiffman MH, Kurman RJ, Barnes W, Jones S, et al. Determinants of genital human papillomavirus infection in low-income women in Washington, D.C. Sex. Transm Dis 1993; 20: 279–85.
   PubMed Web of Science ®Google Scholar
• Karlsson R, Jonsson M, Edlund K, Evander M, Gustavsson A, Boden E, et al. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: A population-based cohort study. Sex Transm Dis 1995; 22: 119–27.
   PubMed Web of Science ®Google Scholar
• Strickler HD, Hildesheim A, Viscidi RP, Shah KV, Goebel B, Drummond J, et al. Interlaboratory agreement among results of human papillomavirus type 16 enzyme-linked immunosorbent assays. J Clin Microbiol 1997; 35: 1751–6.
   PubMed Web of Science ®Google Scholar
• Nonnenmacher B, Krueger Kjaer S, Svare El, Scott JD, Hubbert NL, van den Brute AJ, et al. Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer in high-risk populations. Int J Cancer 1996; 68: 704–9.
   PubMed Web of Science ®Google Scholar
• Dillner J, Knekt P. Boman J, Lehtinen M, af Geijersstam V, Sapp M, et al. Seroepidemiological association between Human Papillomavirus infection and risk of prostate cancer. Int J Cancer 1998; 75: 564–7.
   PubMed Web of Science ®Google Scholar
• Lehtinen M, Dillner J, Knekt P. Luostarinen T, Aromaa A, Kimbauer R, et al. Serologically diagnosed infection with human papillomavirus type 16 and risk for subse-quent development of cervical carcinoma. Br Med J 1996; 312: 537–9.
   Google Scholar
• Dillner J, Lehtinen M, Bjorge T, Luostarinen T, Young-man L, Jellum E, et al. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst 1997; 89: 1293–9.
   Google Scholar
• Kibur M, af Geijersstam V, Pukkala E, Koskela P. Luostarinen T, Paavonen J, et al. Attack rates of Human Papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for post-natal HPV16 vaccination. Sex Transm Inf 2000; 76: 13–7.
   PubMed Web of Science ®Google Scholar
• Olsen A00, Dillner J, Gjöen K, Sauer T, Orstavik I, Magnus P. A population-based case-control study of human papillomavirus type 16 seropositivity and in-cident high-grade dysplasia of the uterine cervix. Int J Cancer 1996; 68: 415–9.
   Google Scholar
• af Geijersstam V, Wang Z, Lewensohn-Fuchs I, Schiller JT, Forsgren M, Dillner J. Trends in seroprevalence of Human Papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989. Int J Cancer 1998; 76: 341–4.
   Google Scholar